Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

COMPUGEN LTD (CGEN)

$2.28 -2.56% NASDAQ: CGEN · 15-min delayed
  • Public · NASDAQ: CGEN
  • 75 employees
  • Founded 1993
$198.6MMarket cap
$72.8MRevenue · FY2025
$35.3MNet income
75Employees
CGENNASDAQ
2000IPO

About COMPUGEN LTD

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$72.8M
Net income
$35.3M
Total assets
$156.6M
Market cap
$198.6M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: CGEN
$2.28 -2.56%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$1.33 $3.10

52-week range

Market cap
$198.6M
Shares outstanding
87.1M
Open
Day range
Prev close
Volume
IPO date
Aug 11, 2000

Compugen Ltd (CGEN) Stock Price

  • Profitable — net income of $35.3M in FY2025.
  • Trading 26% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review COMPUGEN LTD.

Write a review
Newsroom

News about COMPUGEN LTD

News & sentiment via Polygon.io

FAQ

Compugen Ltd: frequently asked questions

Is Compugen Ltd an American company?

Compugen Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Compugen Ltd publicly traded?

Yes — Compugen Ltd is a publicly traded company. Its stock trades under the ticker symbol CGEN on the NASDAQ.

What does Compugen Ltd do?

Compugen Ltd is an American Pharmaceuticals company in the Health & Beauty sector.

When was Compugen Ltd founded?

Compugen Ltd was founded in 1993.

Explore

Similar companies

Browse all →